Shopping Cart
- Remove All
- Your shopping cart is currently empty
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $3,320 | 10-14 weeks | |
50 mg | $4,380 | 10-14 weeks | |
100 mg | $6,100 | 10-14 weeks |
Description | ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections. |
Molecular Weight | 315.30 |
Formula | C13H18FN3O5 |
Cas No. | 2209871-83-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.